The Patent Finder

Aderis Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Aderis Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Aderis Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 10,251,844Transdermal Therapeutic System and Method of Use Thereof for Treating Parkinsonism
Formerly held
Term ended
Ended no later than Feb 25, 2024 · Low confidence
Term endedEnded no later than Feb 25, 2024Low confidence
US 10,322,093Method for Producing a Transdermal Therapeutic System Which Contains a D2 Agonist
Formerly held
Term ended
Term ended Sep 22, 2022 · Medium confidence
Term endedTerm ended Sep 22, 2022Medium confidence
US 6,884,434Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
Formerly held
Term ended
Term ended Mar 30, 2021 · From the USPTO record
Term endedTerm ended Mar 30, 2021From the USPTO record
US 6,372,920Process for preparing nitrogen-substituted aminotetralins
Formerly held
Term ended
Term ended Nov 16, 2020 · From the USPTO record
Term endedTerm ended Nov 16, 2020From the USPTO record
US 7,413,747Transdermal Therapeutic System for Treating Parkinsonism
Formerly held
Term ended
Ended no later than Mar 18, 2019 · Low confidence
Term endedEnded no later than Mar 18, 2019Low confidence
US RE37,045N-6 substituted-5'-(N-substituted carboxamide)adenosines as cardiac vasodilator and antihypertensive agents
Term ended
Term ended Jan 21, 2019 · From the USPTO record
Term endedTerm ended Jan 21, 2019From the USPTO record
US RE36,4942-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
Term ended
Term ended Jan 11, 2017 · From the USPTO record
Term endedTerm ended Jan 11, 2017From the USPTO record
US 6,372,723Compositions and methods for preventing restenosis following revascularization procedures
Lapsed on the fee record
Ended Apr 16, 2010 · From the USPTO record
Lapsed on the fee recordEnded Apr 16, 2010From the USPTO record
US 6,339,072Compositions and methods for preventing restenosis following revascularization procedures
Lapsed on the fee record
Ended Jan 15, 2010 · From the USPTO record
Lapsed on the fee recordEnded Jan 15, 2010From the USPTO record
US 6,784,165Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
Lapsed on the fee record
Ended Aug 31, 2008 · From the USPTO record
Lapsed on the fee recordEnded Aug 31, 2008From the USPTO record
10 of 37 patents shown.
Pro members see all 37.
Pro members: see all 37 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited